Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer

Background: The selection of appropriate chemotherapy backbone agents in combination with neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) remains unclear. Herein, we aimed to evaluate the efficacy and safety of anthracycline-free and anthracycline-containing regimens coupled with...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuhan Wei, Qiao Li, Hongnan Mo, Yalong Qi, Hewei Ge, Xiaoying Sun, Ying Fan, Pin Zhang, Jiayu Wang, Yang Luo, Jing Wang, Fei Ma
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Translational Oncology
Subjects:
PD-1/PD-L1 Inhibitors
Anthracycline-free regimens
Triple-negative breast cancer
Neoadjuvant therapy
Real-world study
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523324002973
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1936523324002973

Similar Items